The skin graft market plays an important role in modern wound care and reconstructive surgery, providing solutions for patients with burns, extensive wounds, trauma, and skin cancer. Skin grafting involves surgically transferring a section of skin to an injured or affected area to support wound closure and tissue repair.

Market Size and Growth

The skin graft market was valued at US$ 985.4 million in 2020 and is projected to reach US$ 1,673.5 million by 2028; it is expected to grow at a CAGR of 7.0% from 2021 to 2028.

The market growth is supported by the increasing incidence of burn injuries, extensive wounds, skin cancer, and diabetes-related wounds. The growing need for effective wound management and reconstructive procedures is encouraging healthcare providers to adopt advanced grafting techniques and associated surgical equipment. At the same time, improvements in graft preparation, transplantation procedures, and wound-care technologies are contributing to broader clinical applications.

Get Sample PDF - https://www.theinsightpartners.com/sample/TIPHE100001099

Rising Prevalence of Skin Cancer and Diabetes

The increasing prevalence of skin cancer is an important factor supporting demand for skin grafting procedures. Skin grafts may be used following skin cancer surgery to close surgical wounds and support tissue reconstruction. As the number of skin cancer cases rises globally, demand for procedures capable of restoring damaged skin is expected to increase.

Diabetes is another significant factor influencing the market. Patients with diabetes can experience delayed wound healing and have an increased risk of complications associated with chronic wounds. Diabetic foot ulcers may require advanced wound-care interventions, including skin grafting in appropriate cases. The growing global diabetes burden therefore creates opportunities for skin graft products and technologies designed to support wound closure and tissue regeneration.

Increasing Burn Injuries and Extensive Wounds

Burn injuries remain a major application area for skin grafting. Severe burns can result in substantial skin loss, making surgical reconstruction essential for wound coverage and recovery. Skin grafts can help protect exposed tissue, promote healing, and support restoration of damaged areas.

The extensive wound segment also contributes to market demand. Trauma, surgical wounds, and other conditions involving significant tissue damage can require grafting procedures. The continuing need for specialized wound management across hospitals and surgical centers is expected to sustain demand for skin graft technologies.

Product-Based Market Insights

Based on product, the skin graft market is segmented into autologous, allogeneic, xenogeneic, prosthetic, and isogeneic grafts. Autologous grafts held the largest market share in 2020 and are anticipated to maintain strong growth. These grafts use skin obtained from another part of the patient's own body and are widely utilized in the treatment of burns and open wounds.

The clinical advantages associated with using a patient's own tissue support the continued adoption of autologous grafting. Meanwhile, developments in alternative graft technologies are expanding treatment options for patients requiring skin reconstruction.

Graft Thickness and Equipment Trends

The market is categorized by graft thickness into split-thickness, full-thickness, and composite grafts. Split-thickness grafts are anticipated to witness the fastest growth, with the segment projected to register a CAGR of 7.6% during the forecast period. Their broad use in wound coverage and burn treatment supports their growing adoption.

By equipment, the market includes dermatomes, general surgical instruments, consumables, and other equipment. The dermatome segment is anticipated to witness the fastest growth, registering a CAGR of 7.7% over the forecast period. Increasing use of specialized surgical instruments for harvesting skin grafts is contributing to demand for dermatome equipment.

Application and End-User Landscape

Based on application, the market is segmented into burns, extensive wounds, skin cancer, and other applications. Burns represented the largest application segment in 2020, accounting for 52.5% of the market. The segment is also estimated to register the highest CAGR during the forecast period, reflecting the continuing requirement for reconstructive treatment following severe burn injuries.

Hospitals accounted for the largest share among end users in 2020, representing 56% of the market. Hospitals perform a substantial volume of complex surgical procedures and provide specialized care for patients with burns, trauma, chronic wounds, and skin cancer. Ambulatory surgical centers and dermatology clinics also represent important end-user settings as specialized procedures increasingly expand beyond traditional hospital environments.

Regional Market Landscape

North America dominated the skin graft market with a 41.1% share in 2020. The region benefits from established healthcare infrastructure, advanced surgical capabilities, and significant demand for wound-care and reconstructive procedures. The United States market is projected to grow at a CAGR of 6.8% over the forecast period.

Asia Pacific is poised to grow at a CAGR of 8.3% over the forecast period, making it an important region for future market opportunities. Increasing healthcare expenditure, expanding medical infrastructure, and growing awareness of advanced wound-care procedures are supporting market development across countries in the region.

Competitive Landscape and Key Players

The skin graft market features established medical technology and regenerative medicine companies competing through product development, strategic partnerships, acquisitions, and geographic expansion. Key players include:

• B Braun SE
• Integra LifeSciences Holdings Corp
• Zimmer Biomet Holdings Inc
• Organogenesis Inc.
• Smith & Nephew Plc
• Tissue Regenix Group
• MiMedx Group Inc
• AVITA Medical
• De Soutter Medical
• Nouvag AG

Companies are focusing on strengthening their product portfolios and responding to changing clinical requirements. Organic strategies such as product launches and expansion, alongside inorganic strategies including partnerships and mergers and acquisitions, are shaping the competitive environment.

Future Outlook

The future outlook for the skin graft market remains positive, supported by rising demand for advanced wound management and reconstructive procedures. Increasing cases of burns, skin cancer, diabetes-related wounds, and extensive trauma are expected to create sustained clinical demand. Technological advancements in grafting techniques, harvesting equipment, and regenerative solutions may further improve treatment options.

Autologous grafts, split-thickness grafts, dermatome equipment, and burn-related applications are expected to remain important areas of opportunity. Meanwhile, the strong growth outlook for Asia Pacific highlights the potential for expansion in emerging healthcare markets. As healthcare providers increasingly emphasize effective wound closure, tissue repair, and patient outcomes, innovation and broader access to skin graft technologies are expected to remain central to market development.

Related Reports @

Wound Care Devices Market Size, Share & Forecast by 2034

Wound Care Market Size, Growth & Demand by 2034

Skin Transplantation Market Developments, Trends, Opportunities, and Forecast by 2034

About Us –

The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.

Contact Us:
Contact Person: Ankit Mathur
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876

Also Available in : Korean German Japanese French Chinese Italian Spanish